| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/14/2001 | US6274343 Conjugate of delivery vehicle having ability to localize at neoplastic tissue and agent which increases blood supply to tissue; anticarcinogenic/antitumor agents; diagnostic imaging |
| 08/14/2001 | US6274340 DNA sequences enhancing promoter activity |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/14/2001 | US6274332 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 08/14/2001 | US6274331 Using recombinant dna vectors which encode di-alpha or di-beta globin-like polypeptide having linker, transforming cells, screening for production by determining response to carbon monoxide, determining amino acid sequence of linker |
| 08/14/2001 | US6274279 Preparations of bacteriorhodopsin variants having increased memory time, and their use |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274139 For therapy of bacterial infections |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | CA2185155C Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 08/14/2001 | CA2037959C Cyclohexapeptides compound |
| 08/14/2001 | CA1341284C Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057217A1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 08/09/2001 | WO2001057216A2 Method for the production of a protein |
| 08/09/2001 | WO2001057211A1 Soluble t cell receptor protein and method of constructing the same |
| 08/09/2001 | WO2001057210A2 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 08/09/2001 | WO2001057199A1 Antibody for detecting mycoplasma pneumoniae |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057090A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 08/09/2001 | WO2001057089A1 Antibody for detecting chlamydia pneumoniae |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001057059A1 Antisense modulation of survivin expression |
| 08/09/2001 | WO2001056603A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000069895A3 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 08/09/2001 | WO2000061729A3 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules |
| 08/09/2001 | WO2000058510A3 Schizophrenia associated genes, proteins and biallelic markers |
| 08/09/2001 | WO2000006713A3 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | US20010012887 Cloning and uses of the genetic locus bcl-6 |
| 08/09/2001 | US20010012836 Determining the presence or absence of a mutation in the nucleotide sequence or absence of a mutation in nucleotide sequence encoding the specific polypeptides in the genome of the subject and analyzing for presence of polypeptide |
| 08/09/2001 | US20010012831 Calcium-binding protein |
| 08/09/2001 | US20010012628 sbgFGF-19a |
| 08/09/2001 | US20010012627 Neurotransmitter transporter SC6 |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012614 Nucleotide sequence from mRNA untranslated regions encoding RNA binding proteins (RBPs) binding proteins; use in drug screening; use in modifying post-transcriptional protein expression |
| 08/09/2001 | US20010012515 Isolated polypeptide |
| 08/09/2001 | EP1144611A3 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399080A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | CA2398998A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | CA2398889A1 Antisense modulation of survivin expression |
| 08/09/2001 | CA2398255A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | CA2396774A1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/08/2001 | EP1122317A1 Antibody against glycerylaldehyde-3-phosphate dehydrogenase and utilization thereof |
| 08/08/2001 | EP1122314A1 Method for the production of a protein |
| 08/08/2001 | EP1122312A1 Novel protein war-1 and gene thereof |
| 08/08/2001 | EP1121600A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121449A1 Delivery system for porcine somatotropin |
| 08/08/2001 | EP1121448A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121433A2 Human ankyrin family protein |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121383A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 08/08/2001 | EP1121382A2 Interferon-beta fusion proteins and uses |
| 08/08/2001 | EP0871776A4 A novel human b cell surface molecule |
| 08/08/2001 | EP0820463A4 Igf-i purification process |
| 08/08/2001 | EP0786004B1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 08/08/2001 | EP0726949B1 Opioid receptor: compositions and methods |
| 08/08/2001 | EP0689587A4 Mutant luciferases |
| 08/08/2001 | EP0669829B1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 08/08/2001 | CN1307642A Method for producing polypeptide by modifying copy number of gene |
| 08/08/2001 | CN1307640A Cell separation device and separation method |
| 08/08/2001 | CN1307638A Host-encoded protein expressed on Marek's disease (MDV)-infected cells and antibody thereto |
| 08/08/2001 | CN1307637A Polynucleotides isolated from skin cells and methods for their use |
| 08/08/2001 | CN1307485A Remedies for hypercalcemic crisis |
| 08/08/2001 | CN1307482A Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/08/2001 | CN1307000A Vaccine for hoof-and-mouth disease and preparing method thereof |
| 08/08/2001 | CN1069346C Expression and secretion of hereologous proteins by yarrowia lipolytica transformants |
| 08/07/2001 | US6271435 Leukotriene B4 receptor transgenic mice |
| 08/07/2001 | US6271381 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271366 Polynucleotide encoding secretory membrane protein |
| 08/07/2001 | US6271365 Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them |
| 08/07/2001 | US6271354 Microorganism fusion polypeptide; for use in treatment of viral diseases; viricides |
| 08/07/2001 | US6271353 Antibodies specific for human adseverin |
| 08/07/2001 | US6271346 TNF Receptors, TNF binding proteins and DNAs coding for them |
| 08/07/2001 | US6271204 Activation of pyruvate dehydrogenase phosphatase |
| 08/07/2001 | US6271025 Modified factor VIII cDNA |
| 08/07/2001 | US6271019 Leukemia associated genes |
| 08/07/2001 | US6271017 Genes of Heliciobacter pylori necessary for the regulation and maturation of urease and their use |
| 08/07/2001 | US6271000 Streptococcus pneumoniae gene sequence mraY |
| 08/07/2001 | US6270999 A streptococcal polynucleotide encoding a polypeptide of the lysyl trna synthetase family; diagnosis and therapy of otitis media, conjunctivitis, pneumonia, meningitis, sinusitis; screening antibiotics |
| 08/07/2001 | US6270998 An isolated nucleic acid involved in apoptosis; diagnosis and therapy of diseases associated with human immunodeficiency virus; antitumor agents |
| 08/07/2001 | US6270993 VEGF-binding polypeptide |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270990 Neuron-restrictive silencer factor proteins |